Issue |
E3S Web of Conf.
Volume 482, 2024
Young Scholar Symposium on Science Education, Earth, and Environment (YSSSEE 2023)
|
|
---|---|---|
Article Number | 01002 | |
Number of page(s) | 7 | |
Section | Ecology, Biodiversity and Ways of its Conservation | |
DOI | https://doi.org/10.1051/e3sconf/202448201002 | |
Published online | 29 January 2024 |
Potential of Gossypetin Compounds and Organic Acids of Rosella Kombucha Tea as Immunomodulators in Malaria Cases: In Silico Study
1 Biology Education, Raden Intan State Islamic University Lampung, Lampung, Indonesia
2 Graduate of the Biology Education Study Program, Raden Intan State Islamic University Lampung, Lampung, Indonesia
Malaria is an infectious disease caused by Plasmodium. Cases of resistance to Artemisin-based Combination Therapy (ACT) have been found. Therefore, complementary therapy is needed. The content of flavonoids (gossypetin) and organic acids (acetic acid, gluconic acid, and lactic acid) in Rosella Kombucha tea may be used as complementary therapy for the treatment of malaria. The In Silico study used gossypetin, acetic acid, gluconic acid, and lactic acid as ligands. While the target protein is the crystal structure of the enzyme TCR - MHC II Complex. Applications used for docking insilico are AutodockTools 1.5.6, Autodock 4.2 and Discovery Studio Visualizer. The results showed that gossypetin and organic acids had the potential to increase the activity of immunocompetent cells because these compounds were able to bind to the TCR – MHC II complex receptor. Gossypetin is more potent than organic acid compounds. gossypetin has Free Energy Binding (∆Gbinding) value (-2.26 kcal/mol), inhibition constant value (22.21 nM) and RMSD value < 5 (2.58). Meanwhile, the most potent organic acid was lactic acid with a value of Free Energy Binding (∆Gbinding) (-1.76 kcal/mol), an inhibition constant value (51.69 nM) and an RMSD value < 5 (4.1).
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.